SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-24-071514
Filing Date
2024-06-14
Accepted
2024-06-14 08:00:45
Documents
13
Period of Report
2024-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2417255d2_8ka.htm   iXBRL 8-K/A 38491
  Complete submission text file 0001104659-24-071514.txt   219591

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rnaz-20240613.xsd EX-101.SCH 3054
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnaz-20240613_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnaz-20240613_pre.xml EX-101.PRE 22385
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2417255d2_8ka_htm.xml XML 4501
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40363 | Film No.: 241043182
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)